Biotechnology Business Plan Template

Written by Dave Lavinsky

Biotechnology Business Plan Template
Table of Contents
Table of Contents

If you’re looking to create a biotechnology business plan, you’ve come to the right place!

Over the past 25 years, the PlanPros team has helped over 1 million entrepreneurs and business owners write business plans….and many of them have started and grown successful biotechnology businesses. Our biotechnology business plan example below is sure to help you!

Biotechnology Business Plan Example

Below is our biotechnology business plan template and sample plan created using our free ai business plan generator:


I. Executive Summary

Company Overview

At BioGenix Solutions, we are a newly established Biotechnology company based in the vibrant city of Austin, TX. Our initiation stems from identifying the need for high-quality local biotechnological services and products, aiming to bridge this gap with our innovative solutions. Our offerings are diverse, including Monoclonal Antibodies, Recombinant Proteins, Gene Therapies, Diagnostic Assays, and Agricultural Biotechnology Products, all tailored to meet the sophisticated needs of our clients. Our strategic location in Austin, alongside our state-of-the-art facilities, empowers us to serve our local clientele with unmatched excellence and innovation in biotechnology.

Success Factors

Our confidence in our future success is rooted in several key factors. The extensive experience and industry knowledge of our founder, who has previously led a successful biotechnology business, guide our strategic direction. Our competitive edge is further sharpened by our superior Diagnostic Assays and a broader variety of Agricultural Biotechnology Products compared to our competitors. Since our inception on January 4, 2024, we have made significant strides, including the development of our brand identity and securing a prime location for our operations. These accomplishments signal our strong market entry and readiness to innovate in the biotechnology sector.

Industry Analysis

The U.S. Biotechnology industry, with a current market size of around $200 billion, is on a trajectory of rapid growth, driven by advancements in gene editing technologies, increased R&D investment, and a rising demand for personalized medicine. Projected to expand at an annual growth rate of 8-10%, this growth presents a fertile ground for BioGenix Solutions. Positioned in Austin, TX, we are poised to leverage these industry trends, offering cutting-edge biotech products and services that cater to the increasing demand, thus positioning ourselves to carve a significant market share in this burgeoning sector.

Customer Analysis

Our primary focus is on serving the health-conscious residents of Austin, TX, who are increasingly seeking personalized healthcare solutions enabled by the latest biotechnological innovations. Additionally, we aim to partner with local healthcare providers, including hospitals and clinics, to offer advanced diagnostic and therapeutic options. Research institutions and universities also form a critical part of our customer base, benefiting from our advanced biotech solutions and services, thus enabling us to tap into a wider audience while staying at the forefront of biotechnological advancements.

Competitive Analysis

Our main competitors include Oppenheimer Biotechnology, Premier Research, and Velocity Clinical Research, each offering unique services and products in the environmental, clinical development, and clinical trial sectors, respectively. BioGenix Solutions distinguishes itself through superior diagnostic assays and an unmatched variety of agricultural biotechnology products. Our deep understanding of the local market, combined with our advanced technological capabilities, positions us uniquely in Austin, TX, enabling us to offer more reliable, efficient, and sustainable biotechnological solutions.

Marketing Plan

BioGenix Solutions is committed to becoming a leader in the biotechnology industry by offering a wide range of innovative products and services, including Monoclonal Antibodies, Recombinant Proteins, Gene Therapies, Diagnostic Assays, and Agricultural Biotechnology Products. Our pricing strategy reflects the high quality and innovation embedded in our offerings. To promote our products and services, we will employ a comprehensive promotional strategy, leveraging online marketing, social media, SEO, email campaigns, and participation in networking events and conferences. This multifaceted approach aims to build brand awareness, engage with our target audience, and establish BioGenix Solutions as a thought leader in the biotechnology industry.

Operations Plan

To ensure operational excellence, BioGenix Solutions will focus on key operational processes including Customer Relationship Management, Research and Development, Quality Control and Assurance, Inventory Management, Operational Efficiency, Financial Management, Marketing and Sales, Human Resources Management, and Regulatory Compliance. Our immediate milestones include securing initial funding, acquiring necessary permits and licenses, establishing a fully-equipped laboratory, hiring key personnel, developing a strong intellectual property portfolio, and achieving $15,000/month in revenue. These steps are critical for our success and lay the foundation for our long-term growth and innovation in the biotechnology sector.

Management Team

Under the leadership of CEO Lillian Baker, BioGenix Solutions boasts a management team with the experience and expertise necessary to achieve our ambitious goals. Baker’s proven track record in the biotechnology industry, combined with her strategic vision, positions BioGenix Solutions for significant achievements and innovations in the field. Our team’s collective experience and dedication are key to driving the company’s success and establishing BioGenix Solutions as a leader in biotechnology.

Financial Plan

To reach our growth objectives, BioGenix Solutions requires $1.99 million in funding. This funding will be allocated towards capital investments such as location buildout, equipment, and IT infrastructure, as well as non-capital investments including working capital, initial rent, staff salaries, marketing and advertising, supplies, and insurance. These investments are critical for establishing our operations, developing our product offerings, and securing our place in the biotechnology market.


Below is an overview of our expected financial performance over the next five years:

FY 1 FY 2 FY 3 FY 4 FY 5
Revenues $2,967,973 $3,213,811 $3,480,011 $3,768,261 $4,080,387
Direct Expenses $1,100,419 $1,156,480 $1,215,397 $1,277,316 $1,342,389
Gross Profit $1,867,554 $2,057,330 $2,264,614 $2,490,945 $2,737,997
Gross Profit (%) 62.9% 64% 65.1% 66.1% 67.1%
Other Expenses $97,085 $100,030 $103,065 $106,192 $109,414
EBITDA $1,770,468 $1,957,300 $2,161,548 $2,384,752 $2,628,583
Depreciation $190,000 $190,000 $190,000 $190,000 $190,000
Amortization $0 $0 $0 $0 $0
Interest Expense $199,000 $199,000 $199,000 $199,000 $199,000
Income Tax Expense $483,514 $548,905 $620,391 $698,513 $783,854
Net Income $897,954 $1,019,395 $1,152,156 $1,297,239 $1,455,729


II. Company Overview

BioGenix Solutions is a pioneering force in the biotechnology landscape located right here in Austin, TX. As a newly established biotechnology company, we pride ourselves on being the first of its kind in the area, offering high-quality, innovative solutions where none previously existed. Our mission is to harness the power of biotechnology to create products and services that significantly improve the lives of our customers and the broader community in Austin.

At BioGenix Solutions, our product line is designed to meet a wide array of needs across different sectors. We specialize in the development and distribution of Monoclonal Antibodies, Recombinant Proteins, and Gene Therapies, all of which are at the forefront of medical biotechnology. Additionally, we offer Diagnostic Assays that surpass the quality and accuracy of what is currently available in the market. For the agricultural sector, we have developed a range of Biotechnology Products aimed at enhancing crop yield and resilience, offering more variety than any of our competitors. Our comprehensive suite of products and services is a testament to our commitment to innovation and excellence in the biotechnology field.

Our headquarters in Austin, TX, not only allows us to serve the local community but also positions us strategically to tap into a vibrant ecosystem of technology and innovation. This location is integral to our operations, enabling us to collaborate closely with local businesses, research institutions, and healthcare providers to ensure that our offerings are both cutting-edge and highly relevant to our customer’s needs.

BioGenix Solutions stands out as a leader in the biotechnology industry for several key reasons. Our founder brings invaluable experience from successfully running a biotechnology business, ensuring that our operations are grounded in proven strategies and a deep understanding of the market. Moreover, our diagnostic assays are recognized for their superior quality, setting new industry standards. In the realm of agricultural biotechnology, we offer an unparalleled range of product varieties, allowing us to meet the diverse needs of our customers. These factors, combined with our commitment to innovation and quality, position us uniquely for success.

Since our founding on January 4, 2024, as a Sole Proprietorship, we have made significant strides in establishing our presence in the biotechnology field. Among our initial accomplishments are the development of a distinctive company logo, the creation of our company name, and securing an ideal location for our operations. These achievements mark just the beginning of our journey towards becoming a cornerstone in the biotechnology industry in Austin and beyond.


III. Industry Analysis

The Biotechnology industry in the United States is currently booming, with a market size of over $200 billion. This industry encompasses a wide range of companies involved in the research, development, and commercialization of biotechnological products and services.

With an expected market growth rate of 8% annually, the Biotechnology industry is projected to reach a market size of over $300 billion by 2025. This growth can be attributed to increasing demand for innovative healthcare solutions, advancements in genetic engineering, and a growing focus on personalized medicine.

Recent trends in the Biotechnology industry, such as the rise of precision medicine, gene editing technologies, and increased investment in biopharmaceuticals, bode well for BioGenix Solutions. As a new Biotechnology company serving customers in Austin, TX, BioGenix Solutions is well-positioned to capitalize on these trends and establish itself as a key player in the industry.


IV. Customer Analysis

Below is a description of our target customers and their core needs.

Target Customers

We will target local residents in Austin, TX, who are increasingly interested in personalized healthcare and wellness solutions. This customer segment is keen on leveraging advanced biotechnological advancements to improve their health outcomes. Our services will cater to this demand by providing cutting-edge, tailored health solutions.

In addition to local residents, we will also focus on academic institutions and research facilities in the area. These organizations are always on the lookout for innovative biotechnological solutions that can aid in their research efforts. By partnering with these institutions, we will provide them with the necessary tools and services to advance their research, developing a symbiotic relationship that fosters innovation in biotechnology.

Furthermore, we will target healthcare providers, including hospitals and clinics, seeking advanced biotechnological tools and services for diagnostic and therapeutic purposes. This segment is critical for our growth as it represents a direct channel to patients who can benefit from our biotechnology solutions. By collaborating closely with healthcare providers, we will tailor our offerings to meet the specific needs of their patients, ensuring our solutions are both effective and accessible.

Customer Needs

BioGenix Solutions meets a crucial demand in the biotechnology market by providing high quality monoclonal antibodies, recombinant proteins, and diagnostic assays. These products are essential for researchers and healthcare providers in Austin, TX, who require reliable and effective tools for diagnostics, research, and therapeutic applications. Customers expect products that not only enhance scientific understanding but also contribute to the advancement of medical treatments.

In addition to offering top-tier biotechnological products, BioGenix Solutions understands the importance of accessibility and support. Customers can count on comprehensive technical support and guidance on product selection and usage. This level of service is vital for ensuring that clients can effectively apply their purchases towards their research goals or clinical needs, thus maximizing the value of their investment.

Furthermore, BioGenix Solutions recognizes the growing demand for innovative solutions in the biotech sector. By staying at the forefront of biotechnology advancements, the company is positioned to introduce new and improved products that cater to the evolving needs of its customers. This commitment to innovation ensures that clients have access to the most advanced tools available, enabling groundbreaking discoveries and developments in the field of biotechnology.


V. Competitive Analysis

Direct Competitors

BioGenix Solutions’s competitors include the following companies:

Oppenheimer Biotechnology: Oppenheimer Biotechnology specializes in environmental biotechnology products and services, particularly in waste management solutions. Their product lineup includes bioremediation agents for oil spills, wastewater treatment, and organic waste decomposition. Pricing varies based on the scale of application and the specific needs of the client, making it flexible for various budget ranges. The company generates revenue from both product sales and consulting services for environmental management projects. Operating primarily in the United States, Oppenheimer Biotechnology serves a range of customers from governmental bodies to private sector companies in industries such as oil and gas, waste management, and municipal services. A key strength of Oppenheimer Biotechnology is its expertise in environmental biotechnology, backed by a strong research and development wing. However, a potential weakness lies in its niche focus, which might limit its appeal to a broader biotech market.

Premier Research: Premier Research focuses on providing clinical research services to the biotech and pharmaceutical industries. Their services include phase I-IV clinical trials, regulatory services, and biostatistics, catering to both small biotech firms and large pharmaceutical companies. Pricing for their services is based on the complexity and duration of the clinical trials, with bespoke solutions offered to meet specific research needs. With global operations, Premier Research has a presence in over 84 countries, enabling it to conduct large-scale international clinical trials. It serves a wide range of customers in the pharmaceutical and biotech sectors, focusing on areas such as oncology, pediatrics, and neurology. Premier Research’s key strength is its global reach and ability to manage complex clinical trials worldwide. This is supported by a robust infrastructure and a deep understanding of international regulatory environments. A potential weakness could be its broad focus, which might dilute its expertise in specific biotech niches.

Velocity Clinical Research: Velocity Clinical Research offers a comprehensive suite of clinical trial management services, specializing in Phase II-IV trials. They provide site management, patient recruitment, and regulatory compliance services. Their pricing model is competitive, aiming to offer cost-effective solutions for both small biotech ventures and large pharmaceutical companies. The company has a strong presence in the United States, with over 16 clinical research sites across the country. Velocity Clinical Research focuses on serving the biotech and pharmaceutical industries, with a particular emphasis on therapeutic areas such as dermatology, neurology, and infectious diseases. Velocity Clinical Research’s strength lies in its integrated network of research sites, which streamlines the clinical trial process and enhances patient recruitment efficiency. However, its concentration in the U.S. may limit its ability to conduct global trials and serve international clients, posing a potential weakness in comparison to competitors with a broader geographical footprint.

Competitive Advantages

At BioGenix Solutions, we pride ourselves on our innovative approach to biotechnology, which sets us apart from the competition in several key areas. One of our most significant competitive advantages lies in our development of superior diagnostic assays. Our team’s commitment to research and development means we can offer assays that are not only more accurate but also more efficient than those of our competitors. This translates into faster, more reliable results for our customers, enabling quicker decision-making in critical health and environmental contexts. Our focus on leveraging cutting-edge technology and methodologies ensures that we stay at the forefront of the biotechnology field, continually enhancing the quality and performance of our diagnostic solutions.

In addition to our advancements in diagnostic assays, we also excel in the realm of agricultural biotechnology. Our extensive range of agricultural biotechnology products is unmatched, catering to a diverse set of needs within the agricultural sector. We understand the importance of sustainability and efficiency in agriculture, which is why our products are designed to not only increase crop yields but also to do so in an environmentally friendly manner. By offering a wider variety of agricultural biotechnology products, we enable farmers and agricultural businesses to find precisely the solutions they need to overcome their unique challenges. This breadth of offering, combined with our commitment to sustainability, positions us as a leader in agricultural biotechnology, ready to meet the demands of a rapidly evolving industry.

Furthermore, our localized approach allows us to deeply understand and cater to the specific needs of our customers in Austin, TX. This customer-centric mindset, coupled with our technological and product-based advantages, enables us to provide unparalleled service and support. Our agility in responding to the changing needs of the market and our ability to innovate quickly give us a distinct edge, ensuring that our customers always have access to the most advanced and effective biotechnology solutions available.


VI. Marketing Plan

Our marketing plan, included below, details our products/services, pricing and promotions plan.

Products, Services & Pricing

BioGenix Solutions emerges as a pivotal player in the biotechnology sector, offering a range of innovative products and services designed to meet the diverse needs of its clientele. With a focus on leveraging cutting-edge biotechnological advancements, the company provides solutions that span across medical, diagnostic, and agricultural fields, ensuring that they cater to a broad spectrum of demands within the industry.

One of the cornerstone offerings of BioGenix Solutions is its monoclonal antibodies, which are crucial in the development of targeted therapies for various diseases, including cancer and autoimmune disorders. These antibodies are engineered to bind to specific antigens, allowing for precise intervention in disease pathways. Clients can expect the average selling price for these monoclonal antibodies to be in the range of $500 to $2000, depending on the specificity and application of the product.

Another significant product line includes recombinant proteins, which are used in a myriad of applications from drug development to research studies. These proteins, produced through recombinant DNA technology, play a vital role in understanding disease mechanisms and developing novel treatments. Prices for recombinant proteins typically range from $100 to $1500, reflecting the complexity and yield of the protein production process.

Gene therapies represent a revolutionary approach in treating and potentially curing genetic disorders by correcting defective genes. BioGenix Solutions offers cutting-edge gene therapy solutions, which are at the forefront of personalized medicine. Given the intricate production processes and the profound impact these therapies can have, their cost can range significantly, with average prices hovering between $2000 to $300,000, depending on the therapy’s complexity and application.

Diagnostic assays provided by BioGenix Solutions play a critical role in the early detection and monitoring of diseases. These assays, which include kits for detecting specific biomarkers or pathogens, are essential tools in clinical diagnostics and research. Customers can access these diagnostic assays at an average price range of $50 to $500, ensuring that accurate and efficient diagnostics are within reach for a wide array of applications.

Lastly, the company delves into the realm of agricultural biotechnology with products aimed at enhancing crop yield, resistance to pests and diseases, and nutritional value. These agricultural biotechnology products are tailored to meet the evolving needs of the agricultural sector, with prices ranging from $100 to $1000. This pricing reflects the technological innovation and value these products bring to the agricultural industry.

In conclusion, BioGenix Solutions stands as a beacon of innovation in the biotechnology landscape, offering a comprehensive suite of products and services that underscore its commitment to advancing healthcare, diagnostics, and agriculture. Through its diverse product lines, the company not only addresses the immediate needs of its clients but also paves the way for future advancements in biotechnology.

Promotions Plan

At BioGenix Solutions, we understand the importance of establishing a strong presence in the biotechnology industry. Our approach to attracting customers revolves around a comprehensive promotional strategy that leverages the latest in online marketing techniques while also incorporating traditional and innovative methods to ensure maximum outreach.

Online marketing stands at the forefront of our promotional efforts. We will utilize search engine optimization (SEO) to increase our website’s visibility in search engine results, making it easier for potential customers to find us when searching for biotechnology solutions. Social media platforms, including LinkedIn, Twitter, and Facebook, will serve as vital tools for engaging with our target audience. By sharing valuable content, industry news, and insights into our services and research, we aim to build a community of followers and advocates for our brand. Additionally, email marketing campaigns will allow us to directly communicate with our audience, providing them with updates, promotional offers, and informative content to keep them engaged with our brand.

Beyond online marketing, we will engage in networking events and conferences within the biotech and related industries. This face-to-face engagement will allow us to build relationships with potential customers, partners, and influencers, fostering a sense of community and collaboration that is vital in our field. Hosting webinars and workshops on relevant topics in biotechnology will further establish BioGenix Solutions as a thought leader, attracting customers who are looking for cutting-edge solutions and insightful industry analysis.

Public relations efforts, including press releases and articles in industry publications, will highlight our innovations, successes, and contributions to the field of biotechnology. This not only enhances our visibility but also builds our credibility among our target audience.

Lastly, we recognize the importance of customer referrals and word-of-mouth. Satisfied customers are our best advocates, and we will encourage them to share their positive experiences with their networks. Incentive programs for referrals will also be put in place, rewarding those who help us grow our customer base.

In summary, BioGenix Solutions will employ a multifaceted promotional strategy that combines the power of online marketing with traditional and innovative methods. By engaging with our audience through multiple channels, we expect to not only attract customers in Austin, TX, but also to build lasting relationships and establish ourselves as leaders in the biotechnology industry.


VII. Operations Plan

Our Operations Plan details:

  1. The key day-to-day processes that our business performs to serve our customers
  2. The key business milestones that our company expects to accomplish as we grow


Key Operational Processes

To ensure the success of BioGenix Solutions, there are several key day-to-day operational processes that we will perform.

  • Research and Development (R&D)
    • Conduct ongoing R&D activities to innovate and improve biotechnology solutions, ensuring our products and services remain at the cutting edge.
    • Monitor scientific literature and patents to avoid infringement and to find opportunities for new product development.
    • Maintain rigorous documentation and compliance with regulatory standards for all research and product development activities.
  • Customer Service and Support
    • Provide comprehensive customer support, including troubleshooting, guidance on product use, and addressing any service queries promptly.
    • Gather customer feedback systematically to improve product offerings and customer experience.
    • Implement a customer relationship management (CRM) system to effectively track and manage customer interactions.
  • Quality Control and Assurance
    • Conduct thorough quality control checks at various stages of the production process to ensure products meet established standards.
    • Implement a continuous improvement process to enhance quality, efficiency, and productivity.
    • Ensure compliance with all relevant regulatory and legal requirements related to biotechnology products and services.
  • Supply Chain Management
    • Maintain relationships with suppliers to ensure the timely delivery of high-quality raw materials.
    • Implement just-in-time inventory management practices to reduce storage costs and ensure freshness of materials.
    • Continuously evaluate and optimize the supply chain for cost-efficiency, reliability, and sustainability.
  • Marketing and Sales
    • Develop and execute a strategic marketing plan to reach target audiences effectively, leveraging both digital and traditional marketing channels.
    • Attend industry conferences and networking events to build brand awareness and establish partnerships.
    • Utilize analytics to measure the performance of marketing campaigns and adjust strategies accordingly.
  • Financial Management
    • Monitor day-to-day financial transactions and manage accounting records to ensure accuracy and compliance with financial regulations.
    • Prepare and review financial statements periodically to assess company performance and inform strategic decision-making.
    • Implement rigorous cost control measures to optimize spending and ensure financial sustainability.
  • Human Resources Management
    • Recruit, train, and retain skilled professionals to support the company’s growth and innovation goals.
    • Develop and maintain a company culture that promotes innovation, teamwork, and employee satisfaction.
    • Ensure compliance with labor laws and regulations, and implement policies that support diversity and inclusion.


BioGenix Solutions expects to complete the following milestones in the coming months in order to ensure its success:

  • Secure Initial Funding and Investors: Obtain the necessary startup capital to fund the initial stages of the business, including laboratory setup, initial staffing, and product development. This is crucial for covering operational costs before the business becomes self-sustaining.
  • Establish a Fully Equipped Laboratory: Set up a state-of-the-art biotechnology laboratory in Austin, TX, equipped with the necessary technology and equipment to begin product development and testing. This will serve as the foundation of BioGenix Solutions’ operations.
  • Obtain Necessary Licenses and Certifications: Ensure compliance with local, state, and federal regulations by obtaining all required permits, licenses, and certifications. This includes any specific biotech industry regulations that are critical to legally operating and selling in the biotechnology market.
  • Develop and Validate Initial Product Offerings: Successfully create and test initial biotechnology products or services to ensure they meet industry standards and are ready for market. This involves rigorous laboratory testing and validation to ensure safety and efficacy.
  • Secure Key Partnerships and Suppliers: Establish relationships with crucial suppliers and partners for materials, equipment, and distribution. This will ensure a reliable supply chain and access to market channels for BioGenix Solutions’ products.
  • Hire and Train a Qualified Team: Build a team of skilled professionals in the biotechnology field, including scientists, lab technicians, sales, and support staff. Training programs should be implemented to ensure all team members are equipped with the necessary knowledge and skills.
  • Launch Marketing and Brand Awareness Campaigns: Implement targeted marketing strategies to build brand awareness in the Austin area and beyond, focusing on the unique value propositions of BioGenix Solutions’ biotechnology offerings.
  • Launch the Biotechnology Business Officially: Mark the official start of operations with a launch event or campaign, signaling to the market that BioGenix Solutions is open for business and ready to serve its customers.
  • Achieve Operational Efficiency: Streamline operations to reduce waste and increase productivity, ensuring that BioGenix Solutions can deliver its products and services effectively at a competitive cost.
  • Reach $15,000/Month in Revenue: Through effective sales strategies, customer relationship management, and market penetration, achieve a milestone of $15,000 in monthly revenue, setting the business on a path to sustainability and growth.


VIII. Management Team

Our management team has the experience and expertise to successfully execute on our business plan.

Management Team Members

BioGenix Solutions management team, which includes the following members, has the experience and expertise to successfully execute on our business plan:

Lillian Baker, CEO

Lillian Baker, CEO of BioGenix Solutions, brings a wealth of experience to the forefront of the biotechnology industry. With a proven track record of leadership and success, Baker has previously helmed a biotechnology business, steering it towards significant achievements. Her strategic vision and deep understanding of the biotech landscape position her as a pivotal figure in guiding BioGenix Solutions towards its goal of achieving lasting success. Baker’s expertise in navigating the complexities of the biotechnology sector, combined with her leadership skills, make her an invaluable asset to the company and its mission to innovate and lead in the field.


IX. Financial Plan


Below is an overview of our expected financial performance over the next five years:

FY 1 FY 2 FY 3 FY 4 FY 5
Revenues $2,967,973 $3,213,811 $3,480,011 $3,768,261 $4,080,387
Direct Expenses $1,100,419 $1,156,480 $1,215,397 $1,277,316 $1,342,389
Gross Profit $1,867,554 $2,057,330 $2,264,614 $2,490,945 $2,737,997
Gross Profit (%) 62.9% 64% 65.1% 66.1% 67.1%
Other Expenses $97,085 $100,030 $103,065 $106,192 $109,414
EBITDA $1,770,468 $1,957,300 $2,161,548 $2,384,752 $2,628,583
Depreciation $190,000 $190,000 $190,000 $190,000 $190,000
Amortization $0 $0 $0 $0 $0
Interest Expense $199,000 $199,000 $199,000 $199,000 $199,000
Income Tax Expense $483,514 $548,905 $620,391 $698,513 $783,854
Net Income $897,954 $1,019,395 $1,152,156 $1,297,239 $1,455,729

Funding Requirements/Use of Funds

To accomplish our growth goals, BioGenix Solutions needs $1.99 million in funding. Key uses of this funding will be as follows:

Capital Investments
Location Buildout $300,000
Furniture $50,000
Equipment & Machines $500,000
Computers and IT Infrastructure $100,000
Non Capital Investments
Working Capital $500,000
Initial Rent/Lease (6 months advance for 5000 sq. ft.) $150,000
Staff Salaries (First 3 months for a team of 10) $300,000
Initial Marketing and Advertising $50,000
Supplies $20,000
Insurance (First Year) $20,000

Financial Projections

financial projection biotechnology business plan

5 Year Annual Income Statement

FY 1 FY 2 FY 3 FY 4 FY 5
Revenues $2,967,973 $3,213,811 $3,480,011 $3,768,261 $4,080,387
Total Revenues $2,967,973 $3,213,811 $3,480,011 $3,768,261 $4,080,387
Direct Costs
Direct Costs $1,100,419 $1,156,480 $1,215,397 $1,277,316 $1,342,389
Total Direct Costs $1,100,419 $1,156,480 $1,215,397 $1,277,316 $1,342,389
GROSS PROFIT $1,867,554 $2,057,330 $2,264,614 $2,490,945 $2,737,997
GROSS PROFIT % 62.9% 64% 65.1% 66.1% 67.1%
Other Expenses
Salaries $72,814 $75,023 $77,299 $79,644 $82,060
Marketing Expenses $6,067 $6,251 $6,441 $6,637 $6,838
Rent/Utility Expenses $6,067 $6,251 $6,441 $6,637 $6,838
Other Expenses $12,135 $12,503 $12,883 $13,274 $13,676
Total Other Expenses $97,085 $100,030 $103,065 $106,192 $109,414
EBITDA $1,770,468 $1,957,300 $2,161,548 $2,384,752 $2,628,583
Depreciation $190,000 $190,000 $190,000 $190,000 $190,000
Amortization $0 $0 $0 $0 $0
EBIT $1,580,468 $1,767,300 $1,971,548 $2,194,752 $2,438,583
Interest Expense $199,000 $199,000 $199,000 $199,000 $199,000
PRETAX INCOME $1,381,468 $1,568,300 $1,772,548 $1,995,752 $2,239,583
Net Operating Loss $0 $0 $0 $0 $0
Use of Net Operating Loss $0 $0 $0 $0 $0
Taxable Income $1,381,468 $1,568,300 $1,772,548 $1,995,752 $2,239,583
Income Tax Expense $483,514 $548,905 $620,391 $698,513 $783,854
NET INCOME $897,954 $1,019,395 $1,152,156 $1,297,239 $1,455,729
Net Profit Margin (%) 30.3% 31.7% 33.1% 34.4% 35.7%

5 Year Annual Balance Sheet

FY 1 FY 2 FY 3 FY 4 FY 5
Cash $1,974,793 $3,168,093 $4,492,658 $5,968,016 $5,603,426
Other Current Assets $254,760 $275,861 $298,711 $314,021 $340,032
Total Current Assets $2,229,553 $3,443,955 $4,791,369 $6,282,037 $5,943,458
Intangible Assets $0 $0 $0 $0 $0
Acc Amortization $0 $0 $0 $0 $0
Net Intangibles $0 $0 $0 $0 $0
Fixed Assets $950,000 $950,000 $950,000 $950,000 $950,000
Accum Depreciation $190,000 $380,000 $570,000 $760,000 $950,000
Net fixed assets $760,000 $570,000 $380,000 $190,000 $0
Preliminary Exp $0 $0 $0 $0 $0
TOTAL ASSETS $2,989,553 $4,013,955 $5,171,369 $6,472,037 $5,943,458
Current Liabilities $101,598 $106,606 $111,863 $115,292 $120,983
Debt outstanding $1,990,000 $1,990,000 $1,990,000 $1,990,000 $0
Total Liabilities $2,091,598 $2,096,606 $2,101,863 $2,105,292 $120,983
Share Capital $0 $0 $0 $0 $0
Retained earnings $897,954 $1,917,349 $3,069,506 $4,366,745 $5,822,474
Total Equity $897,954 $1,917,349 $3,069,506 $4,366,745 $5,822,474
TOTAL LIABILITIES & EQUITY $2,989,553 $4,013,955 $5,171,369 $6,472,037 $5,943,458

5 Year Annual Cash Flow Statement

FY 1 FY 2 FY 3 FY 4 FY 5
Net Income (Loss) $897,954 $1,019,395 $1,152,156 $1,297,239 $1,455,729
Change in Working Capital ($153,161) ($16,094) ($17,592) ($11,881) ($20,319)
Plus Depreciation $190,000 $190,000 $190,000 $190,000 $190,000
Plus Amortization $0 $0 $0 $0 $0
Net Cash Flow from Operations $934,793 $1,193,300 $1,324,564 $1,475,357 $1,625,409
Fixed Assets ($950,000) $0 $0 $0 $0
Intangible Assets $0 $0 $0 $0 $0
Net Cash Flow from Investments ($950,000) $0 $0 $0 $0
Cash from Equity $0 $0 $0 $0 $0
Cash from Debt financing $1,990,000 $0 $0 $0 ($1,990,000)
Net Cash Flow from Financing $1,990,000 $0 $0 $0 ($1,990,000)
Net Cash Flow $1,974,793 $1,193,300 $1,324,564 $1,475,357 ($364,590)
Cash at Beginning of Period $0 $1,974,793 $3,168,093 $4,492,658 $5,968,016
$1,974,793 $3,168,093 $4,492,658 $5,968,016 $5,603,426


What Is a Biotechnology Business Plan?

A biotechnology business plan is a document that outlines the strategies you have developed to start and/or grow your biotechnology business. Among other things, it details information about your industry, customers and competitors to help ensure your company is positioned properly to succeed. Your biotechnology business plan also assesses how much funding you will need to grow your business and proves, via your financial forecasts, why the business is viable.

Why You Need a Business Plan for your Biotechnology Business

A business plan is required if you are seeking funding for your biotechnology business. Investors and lenders will review your plan to ensure it meets their criteria before providing you with capital. In addition, a biotechnology business plan helps you and your team stay focused. It documents the strategies you must follow and gives you financial projections you should strive to achieve and against which you can judge your performance.

Biotechnology Business Plan Template PDF

Download our Biotechnology Business Plan PDF to help guide you as you create your business plan for your own biotechnology business.

Over the past 25 years, Dave Lavinsky, Founder of PlanPros has helped over 1 million entrepreneurs develop business plans.
Create your professional business plan in just minutes using!